Rights Issue Shares in India 2026: How Subscribing, Renouncing, and Letting It Lapse Are Each Taxed

By Nitish Bharadwaj · Published Sep 5, 2026 · 7 min

A rights issue offers existing shareholders three paths — subscribe, renounce (sell the entitlement), or let it lapse — and each carries a distinct tax outcome. Subscribing sets your cost of acquisition at the issue price and starts a fresh holding period from the allotment date. Renouncing is taxed more sharply: Section 55(2)(aa) deems the entitlement's cost of acquisition nil, so the entire sale proceeds become a capital gain, almost always short-term given how briefly entitlements trade. This guide breaks down the tax math for each path.

A rights issue lands in your demat account as an entitlement, not a decision already made — you can subscribe and buy the additional shares, sell that entitlement to someone else, or simply do nothing and let it lapse. Each of those three paths is taxed completely differently, and the most common mistake isn't picking the wrong option — it's assuming the tax treatment mirrors a regular share purchase when it doesn't. Here's exactly how the cost of acquisition, holding period, and capital gains work out under each path.

What a Rights Issue Actually Gives You

When a company raises fresh capital through a rights issue, it offers existing shareholders the right to buy new shares in a fixed ratio to their current holding — commonly something like 1:5, meaning one new share for every five already held — usually at a price below the current market price. Since SEBI mandated that rights entitlements (REs) be credited to shareholders' demat accounts and made tradable on the stock exchange for listed companies, the entitlement itself carries its own ISIN and behaves like a short-lived tradable instrument during the subscription window, typically open for a couple of weeks. That window forces a genuine decision: pay the subscription price to convert the entitlement into actual shares, sell the entitlement itself to another investor for whatever the market is paying, or take no action and let the window close unused.

If You Subscribe — Cost of Acquisition Is the Issue Price, Not Zero

Subscribing to a rights issue and paying the issue price is the most straightforward case: your cost of acquisition for the new shares is exactly what you paid to subscribe, and the holding period for calculating capital gains later starts from the date of allotment of the rights shares — not from whenever you first bought the original shares that made you eligible. This is the detail that catches people out: an investor who has held the parent stock for five years but subscribes to a fresh rights issue today starts an entirely new 12-month clock for those specific shares alone. Sell the rights shares within 12 months and the gain is short-term, taxed at 20% for FY 2026-27; hold past 12 months and it's long-term, taxed at 12.5% above the ₹1.25 lakh annual exemption — the same rates that apply to any other listed equity.

If You Renounce — the Entire Sale Proceeds Are Usually Taxable

Selling your rights entitlement instead of subscribing — renunciation — is treated as a separate capital asset transaction in its own right, and the tax outcome here is sharper than most investors expect. Under Section 55(2)(aa) of the Income Tax Act, the cost of acquisition of a rights entitlement received by virtue of holding the original shares is deemed to be nil. That means when you sell the entitlement for, say, ₹40 per RE, the entire ₹40 is treated as capital gain — there's no cost to net against it, unlike selling the shares themselves. The holding period for this gain runs only from the date the RE was credited to your demat account to the date you sold it — a window that's almost always shorter than 12 months given how briefly REs trade before the subscription period closes, which means renunciation gains are overwhelmingly taxed as short-term capital gains at 20%, regardless of how long you've held the original parent shares.

Why the Renunciation Route Surprises Long-Term Holders

The nil-cost rule for renounced entitlements means the tax bill on selling REs is proportionally higher than most people expect relative to the amount typically involved — there's no purchase cost to net against the gain. Combined with the near-certainty of the gain being short-term because of how briefly REs trade, an investor renouncing ₹50,000 worth of entitlements effectively owes 20% STCG tax on the full ₹50,000, whereas subscribing and later selling the resulting shares after 12 months would have let the same investor pay 12.5% LTCG only above the ₹1.25 lakh exemption threshold — assuming other equity gains that year haven't already used it up. This isn't a reason to avoid renouncing when it's the right financial call, but the difference is worth knowing before deciding purely on which option offers more convenient cash flow.

What Doesn't Trigger Tax

• Simply receiving the rights entitlement in your demat account — there's no tax event until you subscribe, sell, or the window lapses
• Letting the entitlement lapse unused — this only dilutes your proportional shareholding in the company; no capital gain or loss is recognised for tax purposes
• The bonus-style perception that rights shares are "free" — they're not; you're paying the subscription price for every share you receive, and that price is your real cost of acquisition going forward

How This Differs From a Bonus Share

Rights issues and bonus shares get confused often enough that they're worth separating cleanly: a bonus share issue is a free allotment funded from the company's reserves, with a nil cost of acquisition by design and no cash outflow from the shareholder at all. A rights issue, by contrast, requires you to pay the subscription price out of pocket to receive the new shares — the nil-cost treatment under Section 55(2)(aa) applies only to a renounced entitlement, never to shares you actually subscribed and paid for. Confusing the two leads people to assume rights shares carry a zero cost basis the way bonus shares do, which understates their real cost of acquisition and overstates the capital gains tax owed on a later sale.

A rights issue isn't a single event with one tax outcome — it's a three-way fork, and each branch runs on different rules. Subscribing treats the shares like any fresh purchase, with a real cost basis and a clean holding period from allotment. Renouncing treats the sale proceeds as almost entirely taxable gain, usually short-term. Letting it lapse is a non-event for tax purposes, even though it dilutes your stake. Match the decision to your cash flow and conviction in the stock, but go in knowing which of the three tax outcomes you're actually choosing.